My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.
July 27, 2000
NEW YORK, 26 July (Praxis Press) The long-term viral and clinical patterns of hepatitis C virus (HCV) infection are unknown. Thomas and colleagues studied the incidence and determinants of viral clearance and clinical outcome in patients who acquired HCV by injecting drugs. Viral clearance occurred in about 10% of patients during a median follow-up of 8.8 years; clearance occurred more often in non-black patients and in non-HIV-infected patients. End-stage liver disease (ESLD) occurred in about